These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10802800)

  • 1. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.
    Hauser SL; Oksenberg JR; Lincoln R; Garovoy J; Beck RW; Cole SR; Moke PS; Kip KE; Gal RL; Long DT
    Neurology; 2000 May; 54(9):1859-61. PubMed ID: 10802800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up.
    Francis DA; Compston DA; Batchelor JR; McDonald WI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):758-65. PubMed ID: 3497228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple evanescent white dot syndrome and multiple sclerosis].
    Querques G; Bux AV; Forte R; Francesco P; Cristiana I; Noci ND
    J Fr Ophtalmol; 2011 Apr; 34(4):252-5. PubMed ID: 21419509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis.
    CHAMPS Study Group
    Am J Ophthalmol; 2001 Oct; 132(4):463-71. PubMed ID: 11589865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have the optic neuritis treatment trial and the longitudinal optic neuritis study shown us?
    Corbett JJ
    J Neurol Sci; 1994 Aug; 125(1):1-2. PubMed ID: 7964878
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of central nervous system involvement in uncomplicated optic neuritis after prolonged follow-up.
    Kinnunen E; Larsen A; Ketonen L; Koskimies S; Sandström A
    Acta Neurol Scand; 1987 Aug; 76(2):147-51. PubMed ID: 3499741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk].
    Dtsch Med Wochenschr; 1994 Jun; 119(24):897. PubMed ID: 8005072
    [No Abstract]   [Full Text] [Related]  

  • 11. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
    Optic Neuritis Study Group
    Neurology; 1997 Nov; 49(5):1404-13. PubMed ID: 9371930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group.
    Beck RW; Trobe JD
    J Neuroophthalmol; 1995 Sep; 15(3):131-5. PubMed ID: 8574355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical characteristic of optic neuritis and its relevancy with human leukocyte antigen].
    Lai CT; Li W; Sun YB; Meng C; Chi KM; Lu CF; Yu HF; Zhang ZX
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):501-6. PubMed ID: 16857128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study.
    Kheradvar A; Tabassi AR; Nikbin B; Khosravi F; Naroueynejad M; Moradi B; Amirzargar AA
    Mult Scler; 2004 Oct; 10(5):526-31. PubMed ID: 15471368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term prospective study of optic neuritis: evaluation of risk factors.
    Sandberg-Wollheim M; Bynke H; Cronqvist S; Holtås S; Platz P; Ryder LP
    Ann Neurol; 1990 Apr; 27(4):386-93. PubMed ID: 2353793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and magnetic resonance imaging in optic neuritis.
    Jacobs L; Munschauer FE; Kaba SE
    Neurology; 1991 Jan; 41(1):15-9. PubMed ID: 1985282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.
    Hillert J; Käll T; Olerup O; Söderström M
    Acta Neurol Scand; 1996 Sep; 94(3):161-6. PubMed ID: 8899048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis treatment trial. One-year follow-up results.
    Beck RW; Cleary PA
    Arch Ophthalmol; 1993 Jun; 111(6):773-5. PubMed ID: 8512477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings.
    Söderström M; Ya-Ping J; Hillert J; Link H
    Neurology; 1998 Mar; 50(3):708-14. PubMed ID: 9521261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.